Zacks
0
All posts from Zacks
Zacks in Our Research. Your Success.,

Clovis Oncology (CLVS) Catches Eye: Stock Moves 6% Higher

Clovis Oncology, Inc. CLVS was a big mover last session, as its shares rose 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Yesterday’s rally reverses the downtrend for the company, as the stock is now down almost 18% in the past one month time frame.

Over the last 30 days, the company witnessed one negative estimate revision and the Zacks Consensus Estimate also moved lower, signaling trouble ahead. This suggests more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher lasts.

Clovis Oncology currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

A better-ranked biomedical stock is Anika Therapeutics Inc. ANIK with a Zacks Rank #1 (Strong Buy).

Is CLVS going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
ANIKA THERAPEUT (ANIK): Free Stock Analysis Report
 
CLOVIS ONCOLOGY (CLVS): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research